BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE

BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE was reported 53 times

BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROPROSTHESIS IMPLANTATION 1 0.0072
1 INFUSION SITE INJURY 1 0.0057
2 PERIPHERAL NERVE OPERATION 1 0.0046
3 ALLERGY TO ARTHROPOD BITE 1 0.0031
4 IMMUNOGLOBULINS INCREASED 1 0.0021
5 SOLAR LENTIGO 1 0.0011
6 SKIN SENSITISATION 1 0.0010
7 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
8 IMMUNOGLOBULINS DECREASED 1 0.0007
9 VACCINATION FAILURE 1 0.0006
10 BREAST CYST 1 0.0006
11 VOCAL CORD DISORDER 1 0.0005
12 RENAL TUBULAR ACIDOSIS 1 0.0005
13 REACTION TO EXCIPIENT 1 0.0004
14 UTERINE DISORDER 1 0.0004
15 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
16 SUFFOCATION FEELING 1 0.0004
17 HYPERPARATHYROIDISM SECONDARY 1 0.0004
18 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
19 INFUSION SITE REACTION 1 0.0003
20 REBOUND ACID HYPERSECRETION 1 0.0003
21 DYSCHEZIA 1 0.0003
22 PRE-EXISTING CONDITION IMPROVED 2 0.0003
23 INFUSION SITE PRURITUS 1 0.0003
24 INFUSION SITE HAEMORRHAGE 1 0.0003
25 NEPHRITIS 1 0.0003
26 HEPATIC FIBROSIS 1 0.0003
27 EMBOLIC STROKE 1 0.0003
28 CHRONIC SINUSITIS 1 0.0003
29 MUSCLE RUPTURE 1 0.0003
30 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
31 ONYCHOMYCOSIS 1 0.0002
32 PARONYCHIA 1 0.0002
33 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
34 NEPHROGENIC ANAEMIA 1 0.0002
35 ROSACEA 1 0.0002
36 ABDOMINAL TENDERNESS 1 0.0002
37 SENSITIVITY TO WEATHER CHANGE 1 0.0002
38 CARDIOMEGALY 2 0.0002
39 INFUSION SITE SWELLING 1 0.0002
40 THERAPEUTIC RESPONSE CHANGED 1 0.0002
41 DYSGRAPHIA 1 0.0002
42 ULCER HAEMORRHAGE 1 0.0001
43 SEASONAL ALLERGY 2 0.0001
44 ARTHROPOD BITE 1 0.0001
45 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
46 SUBSTANCE ABUSE 1 0.0001
47 MUSCLE INJURY 1 0.0001
48 INFUSION SITE ERYTHEMA 1 0.0001
49 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
50 ANAL INCONTINENCE 1 0.0001
51 OPTIC NEURITIS 1 0.0001
52 NERVE COMPRESSION 1 0.0001
53 SQUAMOUS CELL CARCINOMA 1 0.0001
54 RENAL TUBULAR NECROSIS 1 0.0001
55 LIGAMENT SPRAIN 1 0.0001
56 SUBARACHNOID HAEMORRHAGE 1 0.0001
57 OCULAR DISCOMFORT 1 0.0001
58 DERMATITIS CONTACT 1 0.0001
59 BURSITIS 1 0.0001
60 ROTATOR CUFF SYNDROME 1 0.0001
61 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
62 ORAL CANDIDIASIS 1 0.0001
63 MALIGNANT MELANOMA 1 0.0001
64 LIMB INJURY 2 0.0001
65 CARPAL TUNNEL SYNDROME 1 0.0001
66 SUBDURAL HAEMATOMA 1 0.0001
67 IMPAIRED QUALITY OF LIFE 1 0.0001
68 PULMONARY MASS 1 0.0001
69 CHRONIC KIDNEY DISEASE 5 0.0001
70 HIP ARTHROPLASTY 1 0.0001
71 BASAL CELL CARCINOMA 1 0.0001
72 OBESITY 1 0.0001
73 SCIATICA 1 0.0001
74 BACK DISORDER 1 0.0001
75 CELLULITIS 3 0.0001
76 SCAR 1 0.0001
77 MUSCULOSKELETAL DISCOMFORT 1 0.0001
78 DEVICE DEFECTIVE 1 0.0001
79 HEAD DISCOMFORT 1 0.0001
80 END STAGE RENAL DISEASE 1 0.0001
81 BRONCHITIS 4 0.0001
82 BACTERIAL INFECTION 1 0.0001
83 FRACTURE 1 0.0001
84 FOOT FRACTURE 1 0.0001
85 MUSCULOSKELETAL DISORDER 1 0.0001
86 PULMONARY FIBROSIS 1 0.0001
87 POST PROCEDURAL COMPLICATION 1 0.0001
88 LOWER LIMB FRACTURE 1 0.0001
89 HERNIA 1 0.0001
90 ERUCTATION 1 0.0001
91 SINUS DISORDER 1 0.0001
92 FULL BLOOD COUNT DECREASED 1 0.0000
93 EATING DISORDER 1 0.0000
94 JOINT INJURY 1 0.0000
95 PRODUCT DISPENSING ERROR 1 0.0000
96 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
97 SNEEZING 1 0.0000
98 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
99 MENTAL IMPAIRMENT 1 0.0000
100 FIBROMYALGIA 1 0.0000
101 MOOD ALTERED 1 0.0000
102 SKIN LESION 1 0.0000
103 DIVERTICULITIS 1 0.0000
104 PROCEDURAL PAIN 1 0.0000
105 COMPLETED SUICIDE 3 0.0000
106 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
107 PAIN IN JAW 1 0.0000
108 HYPERSOMNIA 1 0.0000
109 NASAL CONGESTION 2 0.0000
110 IRRITABILITY 2 0.0000
111 MIGRAINE 3 0.0000
112 HYPOTHYROIDISM 1 0.0000
113 HIP FRACTURE 1 0.0000
114 FUNGAL INFECTION 1 0.0000
115 SKIN DISORDER 1 0.0000
116 HYPERKALAEMIA 1 0.0000
117 LYMPHADENOPATHY 1 0.0000
118 CEREBRAL HAEMORRHAGE 1 0.0000
119 PANIC ATTACK 1 0.0000
120 DYSPNOEA EXERTIONAL 1 0.0000
121 INTESTINAL OBSTRUCTION 1 0.0000
122 PLASMA CELL MYELOMA 1 0.0000
123 CARDIAC FAILURE CONGESTIVE 2 0.0000
124 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
125 CARDIO-RESPIRATORY ARREST 1 0.0000
126 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
127 THERAPY NON-RESPONDER 1 0.0000
128 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
129 NEPHROLITHIASIS 1 0.0000
130 NASOPHARYNGITIS 4 0.0000
131 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
132 MULTIPLE SCLEROSIS 1 0.0000
133 BLOOD GLUCOSE DECREASED 1 0.0000
134 CHEST DISCOMFORT 2 0.0000
135 MUSCULOSKELETAL PAIN 1 0.0000
136 DERMATITIS ATOPIC 1 0.0000
137 DRUG EFFECT DECREASED 1 0.0000
138 HAEMATOCHEZIA 1 0.0000
139 NECK PAIN 1 0.0000
140 ABDOMINAL DISCOMFORT 3 0.0000
141 ASTHMA 2 0.0000
142 DEPRESSION 4 0.0000
143 SEIZURE 2 0.0000
144 WHEEZING 1 0.0000
145 CATARACT 1 0.0000
146 INFUSION RELATED REACTION 1 0.0000
147 RENAL FAILURE 2 0.0000
148 DEHYDRATION 2 0.0000
149 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
150 SLEEP DISORDER 1 0.0000
151 MOBILITY DECREASED 1 0.0000
152 RESPIRATORY FAILURE 1 0.0000
153 HOT FLUSH 1 0.0000
154 DIABETES MELLITUS 1 0.0000
155 INJECTION SITE SWELLING 1 0.0000
156 DECREASED APPETITE 3 0.0000
157 ABDOMINAL PAIN 3 0.0000
158 CONFUSIONAL STATE 2 0.0000
159 INFLUENZA LIKE ILLNESS 1 0.0000
160 URINARY TRACT INFECTION 2 0.0000
161 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
162 SUICIDAL IDEATION 1 0.0000
163 OROPHARYNGEAL PAIN 1 0.0000
164 WEIGHT DECREASED 3 0.0000
165 PULMONARY EMBOLISM 1 0.0000
166 FATIGUE 8 0.0000
167 ATRIAL FIBRILLATION 1 0.0000
168 DYSPEPSIA 1 0.0000
169 SOMNOLENCE 2 0.0000
170 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
171 SINUSITIS 1 0.0000
172 HAEMOGLOBIN DECREASED 1 0.0000
173 ILLNESS 1 0.0000
174 ABDOMINAL DISTENSION 1 0.0000
175 PLATELET COUNT DECREASED 1 0.0000
176 OVERDOSE 2 0.0000
177 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
178 CONSTIPATION 2 0.0000
179 FALL 3 0.0000
180 INFLUENZA 1 0.0000
181 BACK PAIN 2 0.0000
182 PALPITATIONS 1 0.0000
183 FEELING ABNORMAL 2 0.0000
184 OEDEMA PERIPHERAL 1 0.0000
185 INJECTION SITE ERYTHEMA 1 0.0000
186 LOSS OF CONSCIOUSNESS 1 0.0000
187 DIARRHOEA 5 0.0000
188 INSOMNIA 2 0.0000
189 PRODUCT QUALITY ISSUE 1 0.0000
190 NEUTROPENIA 1 0.0000
191 VISION BLURRED 1 0.0000
192 COUGH 2 0.0000
193 DYSPNOEA 4 0.0000
194 INFECTION 1 0.0000
195 PRODUCT DOSE OMISSION ISSUE 2 0.0000
196 HYPOAESTHESIA 1 0.0000
197 BLOOD PRESSURE INCREASED 1 0.0000
198 ACUTE KIDNEY INJURY 1 0.0000
199 PAIN 4 0.0000
200 HEADACHE 4 0.0000
201 DRUG DEPENDENCE 1 0.0000
202 PNEUMONIA 2 0.0000
203 DRUG INEFFECTIVE 8 0.0000
204 URTICARIA 1 0.0000
205 TOXICITY TO VARIOUS AGENTS 1 0.0000
206 COVID-19 1 0.0000
207 BLOOD GLUCOSE INCREASED 1 0.0000
208 ABDOMINAL PAIN UPPER 1 0.0000
209 MALAISE 2 0.0000
210 INCORRECT DOSE ADMINISTERED 1 0.0000
211 VOMITING 2 0.0000
212 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
213 DIZZINESS 2 0.0000
214 NAUSEA 3 0.0000
215 ANXIETY 1 0.0000
216 PAIN IN EXTREMITY 1 0.0000
217 INJECTION SITE PAIN 1 0.0000
218 ASTHENIA 1 0.0000
219 PRURITUS 1 0.0000
220 ARTHRALGIA 1 0.0000
221 RASH 1 0.0000
222 OFF LABEL USE 2 0.0000
223 DEATH 1 0.0000